vindeburnol has been researched along with nicergoline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barzaghi, F; Dragonetti, M; Formento, ML; Gueniau, C; Mantegazza, P; Nencioni, A | 1 |
| Barzaghi, F; Boissier, JR; Dragonetti, M; Formento, ML | 1 |
2 other study(ies) available for vindeburnol and nicergoline
| Article | Year |
|---|---|
A comparison of some of the pharmacological properties of the new eburnamenine derivative vindeburnol with those of vincamine, vinburnine, dihydroergotoxine mesilate and nicergoline.
Topics: Animals; Brain Ischemia; Cerebral Cortex; Cerebrovascular Circulation; Cerebrovascular Disorders; Dihydroergotoxine; Electroencephalography; Ergolines; Gerbillinae; Male; Mice; Mice, Inbred Strains; Nicergoline; Rats; Rats, Inbred Strains; Vinca Alkaloids; Vincamine | 1986 |
Effects of the new eburnamenine derivative RU 24722 on EEG recovery and cerebral energy metabolism after complete ischemia.
Topics: Adenosine Triphosphate; Animals; Brain; Brain Ischemia; Dihydroergotoxine; Electroencephalography; Energy Metabolism; Glucose; Glycogen; Lactates; Lactic Acid; Male; Mice; Nicergoline; Phosphocreatine; Rats; Vasodilator Agents; Vinca Alkaloids; Vincamine | 1985 |